Nurse Practitioner, Psychiatric/Mental Health · Hialeah, FL
NPI
1326689761
Since 2019
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4385 W 16th Ave
Hialeah, FL, 33012
Phone (305) 824-0637
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$397K
12,252 prescriptions
Company payments, 2025
$1,293
From 14 companies
Medicare prescription drug claims, 2024
In 2024, the drug Dalida Salgado Artigas prescribed most often to Medicare patients was Escitalopram Oxalate, with 1,144 prescriptions and refills. In total Dalida Salgado Artigas wrote 12,252 Medicare prescriptions that cost $397K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-10.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Escitalopram Oxalate Generic | 1,144 | 1,279 | 198 | $5,627 |
| Mirtazapine Generic | 1,039 | 1,169 | 170 | $6,170 |
| Sertraline Hcl Generic | 899 | 988 | 138 | $9,271 |
| Trazodone Hcl Generic | 893 | 984 | 141 | $3,040 |
| Clonazepam Generic | 876 | 907 | 133 | $3,713 |
| Quetiapine Fumarate Generic | 829 | 905 | 116 | $5,559 |
| Buspirone Hcl Generic | 777 | 822 | 111 | $4,635 |
| Alprazolam Generic | 608 | 613 | 102 | $1,762 |
| Memantine Hcl Generic | 443 | 475 | 78 | $2,795 |
| Duloxetine Hcl Generic | 355 | 386 | 54 | $4,112 |
| Chlordiazepoxide Hcl Generic | 345 | 345 | 64 | $2,269 |
| Fluoxetine Hcl Generic | 343 | 369 | 44 | $1,936 |
| Temazepam Generic | 305 | 312 | 54 | $1,225 |
| Donepezil Hcl Generic | 288 | 314 | 54 | $950 |
| Paroxetine Hcl Generic | 271 | 290 | 43 | $1,593 |
Brand drugs: 380 claims; generic drugs: 11,872 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dalida Salgado Artigas $1,293 ($1,293 in general payments such as food, travel and fees) from 14 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $270.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 19 | $270 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $189 |
| Abbvie Inc. ABBV | 20 | $172 |
| Teva Pharmaceuticals USA, Inc. TEVA | 16 | $166 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $96.53 |
| Alkermes, Inc. ALKS | 5 | $90.18 |
| Lundbeck LLC | 3 | $80.75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $67.24 |
| Almatica Pharma LLC | 2 | $41.17 |
| Collegium Pharmaceutical, Inc. COLL | 2 | $38.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.